Sabet, A., Khalaf, F., Mahjoob, S., Al-Zreiqat, A., Biersack, H., & Ezziddin, S. (2013). May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreotate. e-Century Publishing Corporation.
Citação norma ChicagoSabet, Amir, Feras Khalaf, Soha Mahjoob, Abdullah Al-Zreiqat, Hans-Jürgen Biersack, and Samer Ezziddin. May Bone-targeted Radionuclide Therapy Overcome PRRT-refractory Osseous Disease in NET? A Pilot Report On (188)Re-HEDP Treatment in Progressive Bone Metastases After (177)Lu-octreotate. e-Century Publishing Corporation, 2013.
Citação norma MLASabet, Amir, et al. May Bone-targeted Radionuclide Therapy Overcome PRRT-refractory Osseous Disease in NET? A Pilot Report On (188)Re-HEDP Treatment in Progressive Bone Metastases After (177)Lu-octreotate. e-Century Publishing Corporation, 2013.